HIV scientists, doctors, and health economists have gathered in London on 22-24 September to present the clinical and financial case for HIV treatment and other HIV prevention activities to achieve the 2015 global AIDS targets. Under the title Controlling the HIV Epidemic with Antiretrovirals: From Consensus to Implementation, more than 400 delegates considered data about how the latest HIV prevention programmes work.
The Summit was hosted by the International Association of Providers of AIDS Care (IAPAC) in partnership with the British HIV Association (BHIVA), Public Health England (PHE), and the Joint United Nations Programme on HIV/AIDS (UNAIDS).
Speaking at the opening, UNAIDS Executive Director, Michel Sidibé highlighted the importance of accelerating access to HIV treatment saying that HIV treatment should be available to everyone who needs it. Following the key note speech, high-level panel members discussed HIV treatment expansion; the importance of using data to expand programmes; the need to maximize impact with the resources available; and the need to empower communities to deliver HIV services.
